ArticleCureus2024
Management of Cutaneous Adverse Drug Reactions via Personalized Ayurvedic Interventions: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous adverse drug reactions (CADRs), challenging medication reactions, significantly impact patient well-being and management. This case report presents the successful management of CADR (Aushadha anurjata janya twak vikara) in Ayurveda. This study uniquely demonstrates the efficacy and long-term success of personalized Ayurvedic interventions in managing treatment-resistant drug-induced dermatitis (ADR) exacerbated by conventional treatments, contributing insights into integrative approaches for drug-induced skin reactions and their potential for sustained remission. The condition involved widespread erythematous rashes, severe burning sensations, and skin scaling, which worsened after conventional medication use. Clinical findings revealed extensive skin involvement, characterized by erythema (redness) and epidermal barrier dysfunction (skin disruption). The patient was diagnosed with inflammatory, drug-induced skin manifestations, corresponding to Pitta-predominant characteristics in Ayurveda, and was prescribed personalized treatments, including herbal and herbo-mineral formulations such as Shirisharishta, Khadirarishta, Panchanimba churna, Rasamanikya, Gandhaka Rasayana, and Tankana Bhasma, and topical applications of medicated oils and decoctions. Out of a total of four visits, treatment led to significant improvement within 2 weeks, near-complete resolution after 3 weeks, and the patient was completely asymptomatic at the fourth visit. He was followed for the next year. One-year follow-up, including biweekly visits (first month), monthly telephone updates (next 5 months), and bimonthly updates (final 6 months), revealed no symptom relapse. This case highlights two key takeaways - the potential of personalized Ayurvedic approaches for managing treatment-resistant drug-induced dermatitis and achieving long-term remission through integrative strategies in complex dermatological cases. This case underscores the need for further research into the role of traditional medicine in managing challenging skin disorders and maintaining prolonged symptom-free periods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.